Home
Finance
Bank Routing Numbers
FedWire
Stock Portfolio Generator
Technical Analysis of Stocks
Best Months to Buy or Sell Stocks
Games
Hangman - Hang 'Em High
Chess
Shuttles Game
Chemistry
Chemical Equation Balancer
Periodic Table of the Elements
Chemical Bond Polarity Calculator
Linear Algebra
Gauss-Jordan Elimination Calculator
Calculate Pivots
Factorize: A=LU
Inverse Matrix Calculator
Null Space Calculator
Column Space Calculator
Row Space Calculator
Multiply Two Matrices
AI
Genetic Algorithms
Genetic Algorithms Stock Portfolio Generator
Shuttles Game
Tic-Tac-Toe Game
Personality Profile
Checkers Game
Scripts
Scan for all machines running IIS in a domain
Extract data from a Microsoft Word document
Outlook Scripts
Excel Scripts
IT
How to Stop a DDOS Attack
Subnet Calculator
Fingerprint Web Server
Whois Lookup
InternetPeriscope
About
My Favorite Links
Resume
View My Profile on LinkedIn
View My Profile on DataCamp
View My Profile on Pluralsight
Back to FDA Applications sponsored by GLAXOSMITHKLINE
FDA Drug Application 021078 by GLAXOSMITHKLINE
Application Number
021078
Application Type
New Drug Application
Sponsor Applicant
GLAXOSMITHKLINE
Most Recent Label Available Flag
Current Patent Flag
Action Type
Approval
Chemical Type
New combination
Therapeutic Potential
Priority
Orphan Code
Action Type
Duplicate Counter
Action Date
Document Type
Application Document ID
Sequence Number
Document Title
Document URL
Document Date
AP
0
7/14/2000
N
5911
000
http://www.accessdata.fda.gov/drugsatfda_docs/nda/2000/021078_malarone.cfm
6/16/2003
AP
0
7/14/2000
N
5912
000
http://www.accessdata.fda.gov/drugsatfda_docs/nda/2000/21-078_Malarone_Approv.pdf
6/16/2003
AP
0
7/14/2000
N
5913
000
http://www.accessdata.fda.gov/drugsatfda_docs/nda/2000/21-078_Malarone_Prntlbl.pdf
6/16/2003
AP
0
2/28/2002
SLR
3515
001
http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2002/21078s001ltr.pdf
2/28/2002
AP
0
2/28/2002
SLR
14436
001
http://www.accessdata.fda.gov/drugsatfda_docs/nda/2002/021078_s001_MalaroneTOC.cfm
7/10/2006
AP
0
9/3/2004
SLR
10137
002
http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2004/21078s002ltr.pdf
9/7/2004
AP
0
9/3/2004
SLR
10138
002
http://www.accessdata.fda.gov/drugsatfda_docs/label/2004/21078s002lbl.pdf
9/7/2004
AP
0
8/2/2002
SE8
3513
003
http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2002/21078se8-003ltr.pdf
8/2/2002
AP
0
8/2/2002
SE8
3514
003
http://www.accessdata.fda.gov/drugsatfda_docs/label/2002/21078s3lbl.pdf
8/2/2002
AP
0
8/2/2002
SE8
14435
003
http://www.accessdata.fda.gov/drugsatfda_docs/nda/2002/021078_s003_MalaroneTOC.cfm
7/10/2006
AP
0
5/13/2002
SCS
14431
004
http://www.accessdata.fda.gov/drugsatfda_docs/nda/2002/021078_s004_MalaroneTOC.cfm
7/10/2006
AP
0
5/9/2003
S
14432
005
http://www.accessdata.fda.gov/drugsatfda_docs/nda/2003/021078_s005_MalaroneTOC.cfm
7/10/2006
AP
0
12/2/2003
SE5
7057
006
http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2003/21078se5-006ltr.pdf
12/8/2003
AP
0
12/2/2003
SE5
7068
006
http://www.accessdata.fda.gov/drugsatfda_docs/label/2003/21078se5-006_malarone_lbl.pdf
12/8/2003
AP
0
11/24/2004
SLR
10678
007
http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2004/21078s007ltr.pdf
12/2/2004
AP
0
11/24/2004
SLR
10715
007
http://www.accessdata.fda.gov/drugsatfda_docs/label/2004/21078s007lbl.pdf
12/3/2004
AP
0
2/27/2005
SLR
11197
008
http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2005/021078s008,009ltr.pdf
3/3/2005
AP
0
2/27/2005
SLR
11205
008
http://www.accessdata.fda.gov/drugsatfda_docs/label/2005/021078s008,009lbl.pdf
3/3/2005
AP
0
2/27/2005
SLR
11198
009
http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2005/021078s008,009ltr.pdf
3/3/2005
AP
0
2/27/2005
SLR
11206
009
http://www.accessdata.fda.gov/drugsatfda_docs/label/2005/021078s008,009lbl.pdf
3/3/2005
AP
0
12/4/2007
SLR
18861
012
http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2007/021078s012ltr.pdf
1/9/2008
AP
0
5/7/2008
SLR
19797
014
http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2008/021078s014ltr.pdf
5/9/2008
AP
0
5/7/2008
SLR
19986
014
http://www.accessdata.fda.gov/drugsatfda_docs/label/2008/021078s014lbl.pdf
6/12/2008
AP
0
12/18/2008
SLR
21416
016
http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2008/021078s016ltr.pdf
12/29/2008
AP
0
12/18/2008
SLR
21451
016
http://www.accessdata.fda.gov/drugsatfda_docs/label/2008/021078s016lbl.pdf
1/2/2009
AP
0
9/2/2009
SLR
23754
017
http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2009/021078s017ltr.pdf
11/9/2009
AP
0
2/27/2013
SLR
35297
022
http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2013/021078Orig1s022ltr.pdf
3/1/2013
AP
0
2/27/2013
SLR
35316
022
http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/021078s022lbl.pdf
3/1/2013
Back to FDA Applications sponsored by GLAXOSMITHKLINE